[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Filomeni G, Aquilano K, Civitareale, et al
In a recent study Sun et al
In addition to using genetically engineered bacteria as drug delivery carriers, extracellular vesicles (EVs), especially exocrine bodies, originate from cells through exocytosis and are absorbed by target cells, which can transmit biological signals or even deliver drugs between local or distant cells (47)
We then compared the renal efficiency of carnitine and TMAO excretion by using fractional excretion of carnitine (FeCarnitine) and fractional excretion of TMAO (FeTMAO) referenced with a clinical formula, FeNa [22]
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study